These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23953078)

  • 1. Breaking down patient and physician barriers to optimize glycemic control in type 2 diabetes.
    Ross SA
    Am J Med; 2013 Sep; 126(9 Suppl 1):S38-48. PubMed ID: 23953078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers to effective insulin treatment: the persistence of poor glycemic control in type 2 diabetes.
    Ross SA; Tildesley HD; Ashkenas J
    Curr Med Res Opin; 2011 Nov; 27 Suppl 3():13-20. PubMed ID: 21942467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partnering with patients to improve therapeutic outcomes: incretin-based therapy for type 2 diabetes.
    Nadeau DA
    Postgrad Med; 2010 May; 122(3):7-15. PubMed ID: 20463409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming barriers to insulin replacement.
    Kuritzky L
    J Fam Pract; 2009 Aug; 58(8 Suppl):S25-31. PubMed ID: 19679028
    [No Abstract]   [Full Text] [Related]  

  • 5. Patient adherence to medication requirements for therapy of type 2 diabetes.
    Bailey CJ; Kodack M
    Int J Clin Pract; 2011 Mar; 65(3):314-22. PubMed ID: 21314869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges associated with insulin therapy in type 2 diabetes mellitus.
    Edelman S; Pettus J
    Am J Med; 2014 Oct; 127(10 Suppl):S11-6. PubMed ID: 25282008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving patient acceptance and adherence in diabetes management: a focus on insulin therapy.
    Rakel RE
    Adv Ther; 2009 Sep; 26(9):838-46. PubMed ID: 19768641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of inhaled insulin in the treatment of type 2 diabetes.
    Davis SN
    J Diabetes Complications; 2008; 22(6):420-9. PubMed ID: 18413196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin therapy for maximal glycemic control in type 2 diabetes mellitus.
    Spellman CW
    J Am Osteopath Assoc; 2007 Jul; 107(7):260-9. PubMed ID: 17682113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approaches to help people with diabetes overcome barriers for improved health outcomes.
    Siminerio LM
    Diabetes Educ; 2008; 34 Suppl 1():18S-24S. PubMed ID: 18268002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoglycemic potential of current and emerging pharmacotherapies in type 2 diabetes mellitus.
    Brunton SA
    Postgrad Med; 2012 Jul; 124(4):74-83. PubMed ID: 22913896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pen devices to improve patient adherence with insulin therapy in type 2 diabetes.
    Goldstein HH
    Postgrad Med; 2008 Sep; 120(3):172-9. PubMed ID: 18824835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical inertia in management of T2DM.
    Zafar A; Davies M; Azhar A; Khunti K
    Prim Care Diabetes; 2010 Dec; 4(4):203-7. PubMed ID: 20719586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Removing barriers to insulin use.
    Minze MG; Dalal K; Irons BK
    J Fam Pract; 2011 Oct; 60(10):577-80. PubMed ID: 21977484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating advances in insulin into clinical practice: Effective utilization of insulin in patient management.
    Heile MK; Reid TS
    J Fam Pract; 2013 Sep; 62(9 Suppl Insulin):S18-31. PubMed ID: 24080570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic burden of hypoglycemia in patients with Type 2 diabetes.
    Liu S; Zhao Y; Hempe JM; Fonseca V; Shi L
    Expert Rev Pharmacoecon Outcomes Res; 2012 Feb; 12(1):47-51. PubMed ID: 22280196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.
    Yki-Järvinen H
    Diabetes Metab Res Rev; 2002; 18 Suppl 3():S77-81. PubMed ID: 12324990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probable hypoglycemic adverse drug reaction associated with prickly pear cactus, glipizide, and metformin in a patient with type 2 diabetes mellitus.
    Sobieraj DM; Freyer CW
    Ann Pharmacother; 2010; 44(7-8):1334-7. PubMed ID: 20516361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiologic insulin replacement in type 2 diabetes: optimizing postprandial glucose control.
    Robertson C
    Diabetes Educ; 2006; 32(3):423-32. PubMed ID: 16772658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementing an intravenous insulin protocol in your practice: practical advice to overcome clinical, administrative, and financial barriers.
    Kelly JL; Hirsch IB; Furnary AP
    Semin Thorac Cardiovasc Surg; 2006; 18(4):346-58. PubMed ID: 17395032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.